# Core 01: Cancer Pharmacology

> **NIH NIH P30** · DANA-FARBER CANCER INST · 2020 · $242,642

## Abstract

Cancer Pharmacology Shared Resource
Project Summary / Abstract
The Cancer Pharmacology Core provides the necessary expertise and resources to design and undertake
pharmacokinetic (PK) studies in Phase I and II clinical trials, and preclinical investigations. Services include the
implementation and validation of previously developed analytical methods to quantify drugs and their
metabolites in biological fluids, and modification or development of new assays. The Core also offers
comprehensive analysis of PK data, including the estimation of PK parameters and identifying their relationship
to pathophysiological variables and pharmacodynamic effects.

## Key facts

- **NIH application ID:** 9842670
- **Project number:** 5P30CA006516-55
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** JEFFREY G SUPKO
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $242,642
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9842670

## Citation

> US National Institutes of Health, RePORTER application 9842670, Core 01: Cancer Pharmacology (5P30CA006516-55). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9842670. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*